Crefmirlimab Berdoxam (Zirconium-89)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Crefmirlimab Berdoxam (Zirconium-89), covering 2024-07-22 to 2024-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies [Phase 2]